Initially, the general public was told that the two-step Covid vaccines would be effective in helping to build herd immunity by preventing the acquisition and transmission of the disease. However, according to Dr. Rochelle Walensky, CDC Director, the vaccines are not effective in accomplishing those objectives but instead only prevent severe illness and death.
Since the vaccines have not proven to be as effective as first hoped and U.S. public policy restricts the use of oral medications such as hydroxychloroquine and ivermectin despite their effectiveness, boosters are now being touted as the solution. In a meeting conducted on September 17th, the Food and Drug Administration vaccine advisory committee met to debate and vote on Pfizer and BioNTech’s application to offer booster shots to the general public.
FDA experts have unexpectedly voted against approving Covid-19 vaccination boosters for anyone over the age of 16 in the USA, citing a lack of long term data and stating that the risks do not outweigh any benefits because the Covid-19 vaccines are killing at least 2 people for every 1 life saved.
Despite the committee's overwhelming vote of 16 - 2 recommending that the FDA not grant approval for the booster, the FDA went against the committee's recommendation and approved the Pfizer-BioNTech Covid-19 vaccine to allow for use of a single booster dose.